Suntrust Banks’s Core Laboratories CLB Stock Holding History

Suntrust Banks’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$273K	Buy	5,871 +1,068	+22%	+$49.7K	﹤0.01%	1155
2019 Q2	$251K	Buy	+4,803	New	+$282K	﹤0.01%	1183
2019 Q1	–	Sell	-3,483	Closed	-$208K	–	1295
2018 Q4	$208K	Sell	3,483 -347	-9%	-$29.9K	﹤0.01%	1179
2018 Q3	$443K	Buy	3,830 +659	+21%	+$74.3K	﹤0.01%	959
2018 Q2	$400K	Sell	3,171 -39	-1%	-$4.75K	﹤0.01%	1001
2018 Q1	$348K	Buy	+3,210	New	+$355K	﹤0.01%	1003
2017 Q3	–	Sell	-2,976	Closed	-$301K	–	1270
2017 Q2	$301K	Buy	2,976 +1,223	+70%	+$132K	﹤0.01%	1055
2017 Q1	$202K	Sell	1,753 -631	-26%	-$73.3K	﹤0.01%	1184
2016 Q4	$285K	Buy	+2,384	New	+$264K	﹤0.01%	1282
2015 Q3	–	Sell	-5,380	Closed	-$612K	–	1267
2015 Q2	$612K	Sell	5,380 -20	-0.4%	-$2.42K	﹤0.01%	793
2015 Q1	$563K	Buy	5,400 +640	+13%	+$68.2K	﹤0.01%	793
2014 Q4	$571K	Buy	4,760 +2,285	+92%	+$300K	﹤0.01%	773
2014 Q3	$361K	Buy	2,475 +1,251	+102%	+$193K	﹤0.01%	1088
2014 Q2	$204K	Buy	+1,224	New	+$218K	﹤0.01%	1356

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Suntrust Banks's CLB Position: Q3 2019 in Review

Suntrust Banks increased its Core Laboratories (CLB) stake by 22% in Q3 2019, buying an estimated $49.7K and bringing the position to 5,871 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #1155.

Suntrust Banks first reported a position in CLB in Q2 2014 and has held it in 14 quarters since. The position peaked at $612K in Q2 2015. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Suntrust Banks held 5,871 shares of Core Laboratories worth $273K as of Q3 2019.
Suntrust Banks bought 1,068 Core Laboratories shares in Q3 2019, an estimated $49.7K.
Core Laboratories made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #1155 holding.
Suntrust Banks first reported a position in Core Laboratories in Q2 2014 and has held it in 14 quarters since.
Suntrust Banks's Core Laboratories position peaked at $612K in Q2 2015.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.